期刊文献+

Anthrax:an update 被引量:4

Anthrax:an update
在线阅读 下载PDF
导出
摘要 Anthrax is a zoonotic disease caused by Bacillus anthracis.It is potentially fatal and highly contagious disease.Herbivores arc the natural host.Human acquire the disease incidentally by contact with infected animal or animal products.In the 18th century an epidemic destroyed approximately half of the sheep in Europe.In 1900 human inhalational anthrax occured sporadically in the United Stales.In 1979 an outbreak of human anthrax occured in Sverdlovsk of Soviet Union.Anthrax continued to represent a world wide presence.The incidence of the disease has decreased in developed countries as a result of vaccination and improved industrial hygiene.Human anthrax clinically presents in three forms,i.e.cutaneous,gastrointestinal and inhalational.About 95%of human anthrax is cutaneous and 5%is inhalational.Gastrointestinal anthrax is very rare(less than 1%).Inhalational form is used as a biological warefare agent. Penicillin,ciprofloxacin(and other quinolones),doxicyclin,ampicillin,imipenem.clindamycin, clarithromycin,vancomycin,chloramphenicol,rifampicin are effective antimicrobials. Antimicrobial therapy for 60 days is recommended.Human anthrax vaccine is available. Administration of anti-protective antigen(PA) antibody in combination with ciprofloxacin produced 90%-100%survival.The combination of CPG-adjuvanted anthrax vaccine adsorbed(AVA) plus dalbavancin significantly improved survival. Anthrax is a zoonotic disease caused by Bacillus anthracis.It is potentially fatal and highly contagious disease.Herbivores arc the natural host.Human acquire the disease incidentally by contact with infected animal or animal products.In the 18th century an epidemic destroyed approximately half of the sheep in Europe.In 1900 human inhalational anthrax occured sporadically in the United Stales.In 1979 an outbreak of human anthrax occured in Sverdlovsk of Soviet Union.Anthrax continued to represent a world wide presence.The incidence of the disease has decreased in developed countries as a result of vaccination and improved industrial hygiene.Human anthrax clinically presents in three forms,i.e.cutaneous,gastrointestinal and inhalational.About 95%of human anthrax is cutaneous and 5%is inhalational.Gastrointestinal anthrax is very rare(less than 1%).Inhalational form is used as a biological warefare agent. Penicillin,ciprofloxacin(and other quinolones),doxicyclin,ampicillin,imipenem.clindamycin, clarithromycin,vancomycin,chloramphenicol,rifampicin are effective antimicrobials. Antimicrobial therapy for 60 days is recommended.Human anthrax vaccine is available. Administration of anti-protective antigen(PA) antibody in combination with ciprofloxacin produced 90%-100%survival.The combination of CPG-adjuvanted anthrax vaccine adsorbed(AVA) plus dalbavancin significantly improved survival.
出处 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2011年第6期496-501,共6页 亚太热带生物医学杂志(英文版)
关键词 ANTHRAX Bacillus ANTHRACIS ZOONOTIC DISEASE Contagious DISEASE CUTANEOUS ANTHRAX INHALATIONAL ANTHRAX Gastrointestinal ANTHRAX Human ANTHRAX Anthrax Bacillus anthracis Zoonotic disease Contagious disease Cutaneous anthrax Inhalational anthrax Gastrointestinal anthrax Human anthrax
  • 相关文献

参考文献26

  • 1Dennis M. Klinman,Debra Tross.A single-dose combination therapy that both prevents and treats anthrax infection[J]. Vaccine . 2009 (12)
  • 2Farhang Babamahmoodi,Fereshteh Aghabarari,Abbas Arjmand,G. Hossein Ashrafi.Three rare cases of anthrax arising from the same source[J]. Journal of Infection . 2005 (4)
  • 3Jennifer M Streit,Thomas R Fritsche,Helio S Sader,Ronald N Jones.Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates[J]. Diagnostic Microbiology & Infectious Disease . 2004 (2)
  • 4George Sternbach.The history of anthrax[J]. Journal of Emergency Medicine . 2003 (4)
  • 5Vladimir A Karginov,Tanisha M Robinson,Jenny Riemenschneider,Basil Golding,Michael Kennedy,Joseph Shiloach,Ken Alibek.Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis[J]. FEMS Immunology and Medical Microbiology . 2003 (1)
  • 6Whitney E Jamie.Anthrax: diagnosis, treatment, prevention[J]. Primary Care Update for Ob/Gyns . 2002 (4)
  • 7Itzhak Brook.The prophylaxis and treatment of anthrax[J]. International Journal of Antimicrobial Agents . 2002 (5)
  • 8Itzhak Brook,Thomas B Elliott,Howard I Pryor,Tamar E Sautter,Bryan T Gnade,Jayendrakumar H Thakar,Gregory B Knudson.In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones[J]. International Journal of Antimicrobial Agents . 2001 (6)
  • 9Kelly Morris.US military face punishment for refusing anthrax vaccine[J]. The Lancet . 1999 (9147)
  • 10Lew DP.Bacillus anthracis (anthrax). Principles and Practice of Infectious Diseases . 2000

共引文献1

同被引文献54

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部